• Company Type For Profit
  • Contact Email skidmorecomm@earthlink.net
  • Phone Number 609-860-2260
VaxInnate is a vaccine company that focuses on developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus. It specializes in the fields of healthcare, health diagnostics, and biotechnology. It was founded in 2002 and headquartered in Cranbury, New Jersey.

Lists Featuring This Company

Closed Biotechnology Companies
3,634 Number of Organizations â€¢ $76.5B Total Funding Amount â€¢ 6,411 Number of Investors
Closed Northeastern US Biotechnology Companies
655 Number of Organizations â€¢ $20.6B Total Funding Amount â€¢ 1,424 Number of Investors
Closed Greater New York Area Health Care Companies
618 Number of Organizations â€¢ $3.2B Total Funding Amount â€¢ 464 Number of Investors
Closed United States Health Diagnostics Companies
424 Number of Organizations â€¢ $9.8B Total Funding Amount â€¢ 873 Number of Investors

Frequently Asked Questions

Where is VaxInnate's headquarters? VaxInnate is located in Cranbury, New Jersey, United States.Who invested in VaxInnate? VaxInnate has 9 investors including Saints Capital and National Institute of Allergy and Infectious Diseases.How much funding has VaxInnate raised to date? VaxInnate has raised .When was the last funding round for VaxInnate? VaxInnate closed its last funding round on Sep 28, 2015 from a Venture - Series Unknown round.